Search
for
Sort by
Research 361–390 of 1000+
- Self-reported long COVID-19 symptoms are rare among vaccinated healthcare workers
- Post-COVID-19 syndrome among hospitalized COVID-19 patients: a cohort study assessing patients 6 and 12 months after hospital discharge
- Post-COVID-19 Sydrome and Decrease in Health-Related Quality of Life in Kidney Transplant Recipients after SARS-COV-2 Infection—A Cohort Longitudinal Study from the North of Poland
- Early COVID-19 Therapy with Azithromycin Plus Nitazoxanide, Ivermectin or Hydroxychloroquine in Outpatient Settings Significantly Reduced Symptoms Compared to Known Outcomes in Untreated Patients
- Complications Post-COVID-19 and Risk Factors among Patients after Six Months of a SARS-CoV-2 Infection: A Population-Based Prospective Cohort Study
- Long-COVID-19 clinical and health outcomes: an umbrella review
- Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection – results of a prospective multicenter cohort
- SMART Pharmacists Serving the New Needs of the Post-COVID Patients, Leaving No-One Behind
- Differentiated approach to the implementation of preventive and anti-epidemic measures among military personnel based on the COVID-19 disease risk assessment scale
- Associations between clinical data, vaccination status, antibody responses, and post-COVID-19 symptoms in Thais infected with SARS-CoV-2 Delta and Omicron variants: a 1-year follow-up study
- Persistence of Long-COVID symptoms in a heterogenous prospective cohort
- The Effect of Sex on the Risk of Long-COVID and Cardiovascular Complications in Healthy Patients without Comorbidities: Data from a Polish Long-COVID Cardiovascular (PoLoCOV-CVD) Study
- Acute COVID-19 Syndrome Predicts Severe Long COVID-19: An Observational Study
- Long COVID-19 Effects (Chronic Covid-19 syndrome) in Nepalese Cohort recovered from SARS-CoV-2 infection
- Hydroxychloroquine, nitazoxanide and ivermectin have similar effects in early COVID-19: a head-to-head comparison of the Pre-AndroCoV Trial.
- Azithromycin with nitazoxanide, hydroxychloroquine or ivermectin, with or without dutasteride, for early stage COVID-19: an open-label prospective observational study in males with mild-to-moderate COVID-19 (The Pre-AndroCoV Male Trial).
- Post-COVID-19 syndrome and quality of life impairment in severe COVID-19 Mexican patients
- Long COVID symptoms in hospital employees after post-vaccination SARS-CoV-2 infection in Austria: A study on self-reported incidence and associated factors
- Exploring the landscape of long COVID: prevalence and associated factors in patients assisted by a telehealth service
- Long COVID? What is that?
- Black dots in trichoscopy after COVID‐19. Can it be telogen effluvium?
- Unveiling Post-COVID-19 syndrome: incidence, biomarkers, and clinical phenotypes in a Thai population
- Post-COVID Clinical Manifestations in Non-Hospitalized Patients with COVID-19: A Retrospective Cohort Study
- TCM “medicine and food homology” in the management of post-COVID disorders
- Functional medical approach and management for long COVID
- Long- COVID and general health status in hospitalized COVID-19 survivors
- Análise da qualidade de vida em indivíduos com alopecia pós-COVID-19
- Post-COVID Telogen Effluvium.
- Long COVID: current status in Japan and knowledge about its molecular background
- Prevalence of post–COVID syndrome in a cohort of faculty of a medical institute and their family members